Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1953 1
1955 1
1956 2
1957 3
1958 1
1962 2
1963 1
1964 1
1965 1
1966 2
1967 1
1968 2
1969 3
1970 2
1971 3
1972 1
1974 5
1975 2
1976 2
1977 1
1978 5
1980 1
1981 2
1982 1
1983 11
1984 5
1985 7
1986 2
1987 3
1988 10
1989 13
1990 18
1991 13
1992 22
1993 14
1994 14
1995 15
1996 15
1997 22
1998 11
1999 25
2000 13
2001 27
2002 17
2003 19
2004 22
2005 22
2006 18
2007 27
2008 22
2009 21
2010 33
2011 25
2012 31
2013 36
2014 43
2015 41
2016 53
2017 48
2018 43
2019 55
2020 60
2021 67
2022 68
2023 73
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

1,071 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and Management of Cirrhosis and Its Complications: A Review.
Tapper EB, Parikh ND. Tapper EB, et al. JAMA. 2023 May 9;329(18):1589-1602. doi: 10.1001/jama.2023.5997. JAMA. 2023. PMID: 37159031 Free PMC article. Review.
Approximately 1% to 4% of patients with cirrhosis develop hepatocellular carcinoma each year, which is associated with a 5-year survival of approximately 20%. In a 3-year randomized clinical trial of 201 patients with portal hypertension, nonselective beta-blockers …
Approximately 1% to 4% of patients with cirrhosis develop hepatocellular carcinoma each year, which is associated with a 5-year survival of …
Diagnosis and Management of Hepatic Encephalopathy.
Rudler M, Weiss N, Bouzbib C, Thabut D. Rudler M, et al. Clin Liver Dis. 2021 May;25(2):393-417. doi: 10.1016/j.cld.2021.01.008. Epub 2021 Mar 11. Clin Liver Dis. 2021. PMID: 33838857 Review.
Widespread use of transjugular intrahepatic portosystemic shunt to control complications related to portal hypertension is associated with an increase in HE incidence. If the diagnosis of OHE remains simple in most cases, then the diagnosis of MHE is less codified b …
Widespread use of transjugular intrahepatic portosystemic shunt to control complications related to portal hypertension is ass …
Ascites: diagnosis and management.
Hou W, Sanyal AJ. Hou W, et al. Med Clin North Am. 2009 Jul;93(4):801-17, vii. doi: 10.1016/j.mcna.2009.03.007. Med Clin North Am. 2009. PMID: 19577115 Review.
Ascites is the pathologic accumulation of fluid in the peritoneal cavity and is a common manifestation of liver failure, being one of the cardinal signs of portal hypertension. The diagnostic evaluation of ascites involves an assessment of its cause by determining t …
Ascites is the pathologic accumulation of fluid in the peritoneal cavity and is a common manifestation of liver failure, being one of the ca …
Causes and Management of Non-cirrhotic Portal Hypertension.
Gioia S, Nardelli S, Ridola L, Riggio O. Gioia S, et al. Curr Gastroenterol Rep. 2020 Sep 17;22(12):56. doi: 10.1007/s11894-020-00792-0. Curr Gastroenterol Rep. 2020. PMID: 32940785 Free PMC article. Review.
PURPOSE OF THE REVIEW: Non-cirrhotic portal hypertension (NCPH) includes a heterogeneous group of conditions. ...To now, the management of portal hypertension-related complications in NCPH is the same of those of cirrhosis. ...
PURPOSE OF THE REVIEW: Non-cirrhotic portal hypertension (NCPH) includes a heterogeneous group of conditions. ...To now, the m …
Portal Hypertension and Related Complications: Diagnosis and Management.
Simonetto DA, Liu M, Kamath PS. Simonetto DA, et al. Mayo Clin Proc. 2019 Apr;94(4):714-726. doi: 10.1016/j.mayocp.2018.12.020. Mayo Clin Proc. 2019. PMID: 30947834 Review.
The past several decades have seen major improvements in the clinical management of complications of portal hypertension, resulting in substantial gains in patient outcomes. ...This review focuses on the pathophysiology and diagnosis of portal hypertension …
The past several decades have seen major improvements in the clinical management of complications of portal hypertension, resu …
Optimal management of ascites.
Rudler M, Mallet M, Sultanik P, Bouzbib C, Thabut D. Rudler M, et al. Liver Int. 2020 Feb;40 Suppl 1:128-135. doi: 10.1111/liv.14361. Liver Int. 2020. PMID: 32077614 Free article. Review.
Underlying liver disease must always be treated and may improve ascites. In some patients, ascites is not controlled by medical therapies and has a major impact on quality of life and survival. TIPS placement and liver transplantation must therefore be discussed. More rece …
Underlying liver disease must always be treated and may improve ascites. In some patients, ascites is not controlled by medical therapies …
Non-cirrhotic portal hypertension - diagnosis and management.
Khanna R, Sarin SK. Khanna R, et al. J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23. J Hepatol. 2014. PMID: 23978714 Free article. Review.
In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are indicated in patients with failure of endotherapy, bleeding from sites not amenable to endotherapy, symptomatic hypersplenism or symptomatic …
In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are …
Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.
Intagliata NM, Caldwell SH, Tripodi A. Intagliata NM, et al. Gastroenterology. 2019 May;156(6):1582-1599.e1. doi: 10.1053/j.gastro.2019.01.265. Epub 2019 Feb 13. Gastroenterology. 2019. PMID: 30771355 Review.
Prompt diagnosis and management of acute symptomatic portal vein thrombosis are essential. Failure to detect and treat thromboses can result in mesenteric ischemia, chronic cavernous transformation, and complications of portal hypertension. ...Management of …
Prompt diagnosis and management of acute symptomatic portal vein thrombosis are essential. Failure to detect and treat thromboses can …
Management of refractory ascites.
Wong F. Wong F. Clin Mol Hepatol. 2023 Jan;29(1):16-32. doi: 10.3350/cmh.2022.0104. Epub 2022 Jun 9. Clin Mol Hepatol. 2023. PMID: 35676862 Free PMC article. Review.
Its pathogenesis is related to significant hemodynamic changes, initiated by portal hypertension, but ultimately leading to renal hypoperfusion and avid sodium retention. Inflammation can also contribute to the pathogenesis of refractory ascites by causing portal …
Its pathogenesis is related to significant hemodynamic changes, initiated by portal hypertension, but ultimately leading to re …
Current knowledge and management of portal vein thrombosis in cirrhosis.
Senzolo M, Garcia-Tsao G, García-Pagán JC. Senzolo M, et al. J Hepatol. 2021 Aug;75(2):442-453. doi: 10.1016/j.jhep.2021.04.029. Epub 2021 Apr 27. J Hepatol. 2021. PMID: 33930474 Review.
Portal vein thrombosis (PVT) is an increasingly recognised complication of cirrhosis whose incidence increases in parallel with the severity of cirrhosis. ...Treatment options include anticoagulants and interventional thrombolytic therapies, which are chosen almost …
Portal vein thrombosis (PVT) is an increasingly recognised complication of cirrhosis whose incidence increases in parallel with the s …
1,071 results